Clinical Study on Savolitinib + Osimertinib in Treatment of EGFRm+/MET+ Locally Advanced or Metastatic NSCLC
Clinical trial NCT05009836 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05009836
- Sponsor
- Hutchison Medipharma Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-06
- Primary completion
- 2028-05-30
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.